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OBJECTIVES: To verify the incidence of facetary and low back pain after a controlled medial branch anesthetic
block in a three-month follow-up and to verify the correlation between the positive results and the
demographic variables.
METHODS: Patients with chronic lumbar pain underwent a sham blockade (with a saline injection) and then a
controlled medial branch block. Their symptoms were evaluated before and after the sham injection and after
the real controlled medial branch block; the symptoms were reevaluated after one day and one week, as well as
after one, two and three months using the visual analog scale. We searched for an association between the
positive results and the demographic characteristics of the patients.
RESULTS: A total of 104 controlled medial branch blocks were performed and 54 patients (52%) demonstrated
.50% improvements in pain after the blockade. After three months, lumbar pain returned in only 18
individuals, with visual analogue scale scores .4. Therefore, these patients were diagnosed with chronic facet
low back pain. The three-months of follow-up after the controlled medial branch block excluded 36 patients
(67%) with false positive results. The results of the controlled medial branch block were not correlated to sex,
age, pain duration or work disability but were correlated with patient age (p,0.05).
CONCLUSION: Patient diagnosis with a controlled medial branch block proved to be effective but was not
associated with any demographic variables. A three-month follow-up is required to avoid a high number of
false positives.
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& INTRODUCTION
The American College of Physicians and the American
Pain Society recommend that patients with low back pain
should be classified into one of three pain categories to
allow for a proper clinical approach: back pain potentially
associated with radiculopathy or spinal stenosis, back pain
potentially associated with another specific spinal cause or
nonspecific low back pain. Although imaging is recom-
mended in cases with specific low back pain (i.e., when
severe or progressive neurologic deficits are present or
when serious underlying conditions are suspected on the
basis of history and physical examination), clinicians should
not routinely obtain imaging or other diagnostic tests in
patients with nonspecific low back pain (1); such patients
can comprise 85% of all patients with lumbar pain
complaints (2). Muscle contractions or myofascial syn-
dromes, intervertebral disc or facet joint problems can cause
the pain (1).
Between 8% and 12% of all patients with lumbar pain
comprise chronic cases, with complaints lasting longer than
three months (3,4). Facet joint disturbances can be respon-
sible for 10% to 50% of all cases of chronic lumbar pain (5-8).
However, clinical history or physical examination cannot
identify facet joint alterations as the origin of pain (7,9-13),
nor does imaging (e.g., radiography, computed tomography
[CT] or magnetic resonance imaging [MRI]) (7,14-16). The
only tool to identify facet joint alterations as the cause of
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pain is the verification of an analgesic response to anesthetic
injections into the zygapophyseal joints or at their nerve
supplies (17-20) and medial dorsal branch blocks are easier
to perform (21). The diagnostic power of the blockade is
based on the assumption that anesthetizing the facet joint or
the capsule containing the innervations would result in pain
relief. A positive result (i.e., pain relief) would mean that the
facet joint is the site from which the pain originates. The
technique of medial dorsal branch block consists of blocking
each of the medial branches that innervate a facet above and
a facet below their corresponding roots and also blocking
the multifidus and interspinous muscles in the region of the
corresponding dermatome (22,23).
However, several studies (20,24-26) have documented a
high rate (varying from 25% to 40%) of false positive
diagnoses in controlled medial branch blocks (CMBs)
depending on the use of different anesthetics or saline
solution as the control. There are many reasons for the high
rates of false positives (e.g., the placebo response, use of
sedation during CMBs, liberal use of anesthesia of the skin
and subcutaneous tissue, use of large volumes of anesthetic,
causing dispersion of anesthetics to other structures) (27).
To minimize false positives, the following solutions are
recommended: using saline controls (7,18,28,29) to avoid
confusion with myofascial pain (24), reducing the amount of
anesthetic applied to 0.5 ml at each point to avoid or reduce
anesthesia of the skin as much as possible and avoiding the
use of sedation for the procedure (7). No study, however,
has investigated CMB after a three-month follow-up to
verify whether the results are the same after such a period.
Therefore, the objective of this study was to determine the
prevalence of low back pain after CMB immediately after
the blocks and also after three months. The hypothesis to be
verified here is that three-months of follow-up can modify
the CMB results, thus, evidencing false-positives and
altering therapeutic planning.
& METHODS
Design, setting and ethics
This prospective, controlled, diagnostic study was per-
formed as the first phase of a randomized controlled clinical
trial conducted by our team to analyze the effect of
neurolysis in chronic facetary lumbar pain (registered in
Clinicaltrials.gov under the number NCT01367860). This
diagnostic study, which concerns the value of a three-month
follow-up in diagnosing facetary pain in patients under-
going controlled medial branch block (CMBs), was ap-
proved by the local ethics committee (under protocol 337/
10); all participants provided signed informed consent. The
patients were informed that the procedure would be
performed without topical analgesia and that there was a
small risk of allergy to the injected lidocaine. The study was
conducted from March 2011 to January 2013.
Sample and participant recruitment
The participants in this study were patients with lumbar
back pain being treated in public primary care settings in
Sa˜o Paulo city; they were referred to our specialized center
or informed by relatives or acquaintances who had learned
of the study and contacted our screening center. The study
was open to anyone with lumbar back pain, regardless of
the region of residence or registration at our hospital. All
participants called the center by telephone and spoke with a
nurse who applied the triage criteria: age (18 to 76 years
old), lumbar back pain for three months or more without a
specific diagnosis and the ability to visit the hospital for
clinical evaluation. The nurse also collected certain demo-
graphic data, such as educational level and marriage status.
Following this assessment, an orthopedic surgeon (IDR)
conducted a clinical evaluation, verifying the presence of
nonspecific chronic back pain and using a visual analog
scale (VAS) to evaluate pain intensity. Pain with a score $4
was a criterion for study inclusion.
The following exclusion criteria were applied: pain
irradiating to the limbs (sciatica), previous lumbar spine
surgery, pregnancy, history of drug abuse, history of
psychiatric problems, rheumatologic diseases, fibromyalgia
or lidocaine allergy, as well as the presence of fever or
neurologic abnormalities in the physical exam. The patients
who did not sign the consent form were also excluded.
Interventions and outcome
For CMB, the patient was positioned in the prone position
and monitored for vital signs. The participant was not
sedated and did not receive any analgesic/anesthetic in the
skin. Once positioned, the patient was asked to note (with a
pencil) the intensity of pain using the VAS.
After the VAS was registered, the patient was warned that
the test would begin with one injection and was asked to
indicate the levels/sites of the most intense back pain. Saline
solution (1 ml) was injected at these sites; 10 minutes later,
the patient was again asked to indicate the pain intensity on
the VAS. If the pain was improved by 50%, a placebo effect
was detected and the patient was immediately excluded
from the study and did not undergo CMB. If the pain was
not improved, CMB was then applied. CMB was performed
with a 25-G needle, 90 mm long, through the skin until
reaching the medial branch nerves in L2, L3, L4 and L5 in
both sides (Figure 1). A dose of 0.5 ml of lidocaine at 2%,
without epinephrine, was used in all cases. All procedures
were performed by the same surgeon (IDR).
After 10 minutes, the patient was again asked to note the
pain intensity using VAS. If the pain improved by only
Figure 1 - A radiograph in the anterior-posterior view during the
controlled medial branch block procedure in one patient, with
needles positioned in the medial branches of L3, L4 and L5 (left).
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#50%, the patient was excluded from the study and was
referred for MRI to investigate the origin of the symptom. If
the pain improved by .50% using VAS, the patient was
included in the study and followed up.
The following day, the patient again visited the center for
pain evaluation. The VAS analysis was repeated after one
week, one month and three months. The VAS score was
expected to be ,4 in these evaluations; a score $4 would be
an indication for neurolysis and the patient would then be
included in the above mentioned clinical trial study. All
VAS scores were recorded for statistical analysis.
Statistical analysis
At the end of the data collection, the patients’ VAS data
were tested for normal distribution with the Kolmogorov-
Smirnov test using histogram subjective analysis. Given a
normal distribution of the data, the averages and standard
deviations were computed and subjected to parametric
tests, including an analysis of variance (ANOVA) to verify
the homogeneity of variance and the t-test for two
independent samples. To analyze the association of dichot-
omous data, Fisher’s exact test and chi-squared tests were
used. For these data, we used the Kruskal-Wallis analysis
for three or more groups and the Wilcoxon test for the
comparison of two groups. For all tests, an alpha error of 5%
was established.
& RESULTS
During the study period, 213 patients were screened by
telephone at the center and 101 (47%) were excluded in this
interview. The remaining 112 were clinically evaluated and
8 (7%) were further excluded: 3 because they did not agree
with the study conditions and 5 because of the exclusion
criteria (Figure 2).
Among the 104 remaining patients who were initially
evaluated with chronic back pain, 50 (48%) were men.
Regarding race, 87 were white (85%), 7 were black (5%), 9
(7%) mulattos and 1 was Asian. Most patients (63%) were
married or had been married for some time (15%). The
patient ages ranged from 29 to 75 years (average,
49.56¡10.97 years). Table 1 shows the educational levels
of the patient cohort.
At the moment of study inclusion, the patients had been
experiencing low back pain for 33.11¡39.85 months. Most
patients (80%) were not using opioids for pain. Regarding
work disability and social security benefits, 41 patients
(39%) had already stopped working and were receiving
government benefits. Among the 63 patients (61%) who
were not receiving benefits, 21 (33%) felt they should receive
benefits because of their pain.
The initial VAS score (before the first injection) was
75.72¡18.20 on average.
Figure 2 - Flowchart detailing the inclusion and exclusion criteria of patients in the diagnostic study.
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Among the 104 individuals subjected to controlled medial
branch block (CMB), 17 (16.3%) felt improvement with the
saline solution injection and were excluded from this study,
as were 33 (31.7%) patients who felt #50% improvement
after the lidocaine injection. These 33 patients were referred
for MRI and then diagnosed with degenerative diseases,
except for one patient who had an osteoid osteoma in S1.
Therefore, this study was completed with 54 patients
undergoing CMB and all VAS evaluations.
The average VAS score immediately after CMB was
43.27¡31.23 (for the entire sample, n = 104). The average
VAS score was 67.78¡20.74 immediately after the CMBs
among the 33 patients who did not respond well to the
lidocaine injection (pain improvement #50%), whereas in
the 54 well-responding patients (pain improvement .50%),
the VAS score was on average 16.7¡12.80. Figure 3 shows
the patient distribution based on pain recurrence after CMB.
The average age of the well-responding patients (n = 41)
was 33.29¡44.53 and the average age of the non-responding
patients (n = 33) was 29.82¡27.82 (p,0.05).
Of the 54 patients, 36 (67%) maintained pain improve-
ment after three months, with a VAS score of 25.40¡9.48.
The remaining 18 (33%) experienced increases in pan, with a
VAS score .4 and these patients were diagnosed with
chronic lumbar facetary pain. Twelve patients (67%) felt
pain again in the first week and 6 (33%) felt pain again one
month after the CMBs.
The investigation of correlations between VAS scores and
demographic variables, including the duration of pain,
showed no significant association between any variable and
VAS scores (p$0.102) or between the demographic variables
and VAS scores before and after CMB (p$0.197).
& DISCUSSION
Imaging exams have been considered to be poor tools to
identify chronic lumbar pain originating from the facet
joints (30-33), as are a patient’s clinical features and history
(25,26). To the best of our knowledge, no controlled study
has investigated the diagnosis of facet joint chronic lumbar
pain using controlled medial branch anesthetic block (CMB)
in an attempt to identify the prevalence of false positives in
a three-month follow-up. Other studies have used CMB as a
diagnostic tool for facet joint pain (34-37), but none have
reevaluated the patients weeks after the blockade. We show
here that it is important to reevaluate patients for weeks
following the CMB procedure because when a patient
begins to feel discomfort again after the effects of the
lidocaine block have passed, it means that the source of pain
was, in fact, the structure being anesthetized. However, as
was the case of 67% of the patients (n = 36) in our sample,
when pain improvement is maintained, it likely indicates
that the symptoms do not originate in the medial branch
nerves, which are no longer anesthetized; most likely, the
cause of pain is myofascial and has been resolved in another
manner. The remaining 33% of patients (n = 18) still had
VAS scores.4 in the three-month follow-up, confirming the
diagnosis of chronic lumbar facetary pain and these patients
began to experience pain again in the first week (12) or first
month (6) after the CMBs.
Patients undergoing CMBs can feel relief for an average of
up to 14 weeks (25,26). In our study, the 36 patients with
improvement after three months most likely had myofascial
pain and the facet joint origin of the pain was correctly
removed after the final follow-up, allowing them to be
treated properly. Other studies did not follow positive
patients after such a period (34-37); in such a situation, these
36 patients could have been inappropriately included in the
neurolysis clinical trial as if they indeed had pain originat-
ing in the facet joint.
False-positive rates can be as high as 38% in CMB using
lidocaine only in patients with low back pain (24). The false
positive rate calculated from the result of bupivacaine-
controlled block 3-4 weeks after the first procedure was
found to be 27% for the lumbar spine (6). Considering that
using a controlled procedure is important, we opted to limit
confounding factors in our research, for instance, avoiding
the use of sedation (7), which can interfere with neuronal
plasticity (38) and restricting the volume of lidocaine to
0.5 ml per injection site, thus eliminating a possible
myofascial effect (39). More importantly, however, was the
use of a controlled block with saline solution (37,40) in a
sham procedure that we were able to implement at the time
of surgery, thereby eliminating the need to utilize the
operating room, staff and materials a second time (with the
associated costs). The placebo and lidocaine injections were
10 minutes apart, which allowed the immediate exclusion of
patients feeling pain improvement with the saline solution.
Our study is most likely representative of the population
(41) because the research was open to the community,
without any restrictions regarding the place of residence or
need for prior registration at our hospital. The patients were
referred from primary care units from across the city or
spontaneously reached us by telephone after being
informed of the project by health professionals or acquain-
tances. In fact, as shown in other studies (6,25,26,42,43), we
found no correlation of the results with demographic data,
such as age, years of schooling or social security benefit.
One of the limitations in the present study is the fact
that we did not evaluate depression symptoms, which could
possibly interfere with chronic pain results. This evaluation
could have been accomplished with scales such as the
Table 1 - Education levels among the patients with
chronic back pain.
Studied for 8 years 35 (33.3%)
Studied for 8-10 years 19 (18.5%)
Completed high school (11 years) 31 (29.6%)
Completed college 19 (18.5%)
Figure 3 - Patient distribution at each evaluation time, according
to their VAS scores (n=54).
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Zung-DV (Zung Self Rating Depression Scale) or MPI-DLV
(Pain-Related Psychosocial and Behavioral Aspects).
Nevertheless, van Wijk et al. (36) used these measures and
observed no differences in depression prevalence between
treated and placebo groups of patients undergoing radio-
frequency denervation. Another study limitation is that,
although we recorded the opioid use by our chronic
low back patients, we did not perform a quantitative or
qualitative analysis on this or any other analgesic. A recent
study has shown, however, that pain sensitivity in chronic
low back pain patients is not altered by chronic opioid
intake (44).
In conclusion, the diagnosis of facet joint lumbar pain
through CMB was proven to be effective but was not
associated with demographic variables. A three-month
follow-up is important to discard myofascial pain cases,
which accounted for 67% of patients undergoing CMB.
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